J&J Must Face Tylenol Liver Damage MDL In Pa.
The decision marks a loss for the defendants, most prominently Johnson & Johnson Inc., that opposed centralization. But the company, along with Perrigo Inc., had conceded that if the litigation was to be consolidated, it should be moved to Pennsylvania.
The six-judge panel agreed that consolidating the litigation in Pennsylvania would be most convenient for the...
To view the full article, register now.